When.com Web Search

  1. Ads

    related to: anoro ellipta generic name

Search results

  1. Results From The WOW.Com Content Network
  2. Umeclidinium bromide/vilanterol - Wikipedia

    en.wikipedia.org/wiki/Umeclidinium_bromide/...

    Umeclidinium bromide/vilanterol, sold under the brand name Anoro Ellipta, among others, is a fixed-dose combination medication for the treatment of chronic obstructive pulmonary disease (COPD). [ 5 ] [ 6 ] It is administered by inhalation.

  3. Vilanterol - Wikipedia

    en.wikipedia.org/wiki/Vilanterol

    Vilanterol is an ultra-long-acting β 2-adrenoceptor agonist which was approved in May 2013 in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD). [1] [2] The combination is also approved for the treatment of asthma in Canada, Europe, Japan [3] and ...

  4. Long-acting beta-adrenoceptor agonist - Wikipedia

    en.wikipedia.org/wiki/Long-acting_beta...

    with umeclidinium bromide: Anoro Ellipta. Umeclidinium bromide is a long-acting muscarinic antagonist. [14] This combination was approved by the FDA on December 18, 2013 [15] for the long-term maintenance treatment of COPD. On March 28, 2014, it was approved in European countries [16] and in Russia [17] under the same trade name.

  5. Could a Pair of Respiratory Disease Treatments Save ... - AOL

    www.aol.com/news/2013-09-16-could-a-pair-of...

    GlaxoSmithKline and its partner Theravance recently scored a second victory in their quest to treat chronic obstructive pulmonary disease, commonly abbreviated as COPD -- an umbrella term that ...

  6. Novartis' Pharmaceutical Business Faces 2 Major Challenges - AOL

    www.aol.com/2013/10/24/novartis-pharmaceutical...

    Diversified health care giant Novartis has had a fairly strong year so far, with its stock price outperforming industry peers GlaxoSmithKline , AstraZeneca, Pfizer, and Merck by a wide margin.

  7. Umeclidinium bromide - Wikipedia

    en.wikipedia.org/wiki/Umeclidinium_bromide

    Umeclidinium bromide, sold under the brand name Incruse Ellipta, is a long-acting muscarinic antagonist approved for the maintenance treatment of chronic obstructive pulmonary disease (COPD). [3] It is also approved for this indication in combination with vilanterol (as umeclidinium bromide/vilanterol ) [ 4 ] [ 5 ] and also as a triple-therapy ...